Your browser doesn't support javascript.
loading
The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database.
Janikova, Andrea; Bortlicek, Zbynek; Campr, Vit; Kopalova, Natasa; Benesova, Katerina; Hamouzova, Michaela; Belada, David; Prochazka, Vit; Pytlik, Robert; Vokurka, Samuel; Pirnos, Jan; Duras, Juraj; Mocikova, Heidi; Mayer, Jiri; Trneny, Marek.
  • Janikova A; Department of Internal Medicine-Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic. janikova.andrea@fnbrno.cz.
  • Bortlicek Z; Department of Hematology and Oncology, University Hospital Brno and Masaryk University Brno, Jihlavska 20, 625 00, Brno, Czech Republic. janikova.andrea@fnbrno.cz.
  • Campr V; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Kopalova N; Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University and Faculty Hospital in Motol, Prague, Czech Republic.
  • Benesova K; Department of Internal Medicine-Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
  • Hamouzova M; 1st Department of Medicine, First Medical Faculty, Charles University and General University Hospital, Prague, Czech Republic.
  • Belada D; 1st Department of Medicine, First Medical Faculty, Charles University and General University Hospital, Prague, Czech Republic.
  • Prochazka V; 4th Department of Internal Medicine-Hematology, Faculty of Medicine, Charles University Hospital, Hradec Králové, Czech Republic.
  • Pytlik R; Department of Hemato-oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic.
  • Vokurka S; 1st Department of Medicine, First Medical Faculty, Charles University and General University Hospital, Prague, Czech Republic.
  • Pirnos J; Department of Hemato-oncology, Charles University and University Hospital Pilsen, Pilsen, Czech Republic.
  • Duras J; Department of Oncology, Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic.
  • Mocikova H; Department of Clinical Hematology, Teaching Hospital Ostrava, Ostrava, Czech Republic.
  • Mayer J; Internal Clinic of Haematology, 3rd Faculty of Medicine, University Hospital Kralovske Vinohrady, Prague, Charles University in Prague, Prague, Czech Republic.
  • Trneny M; Department of Internal Medicine-Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
Ann Hematol ; 97(4): 669-678, 2018 Apr.
Article en En | MEDLINE | ID: mdl-29318369
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Transformación Celular Neoplásica / Linfoma Folicular / Rituximab / Antineoplásicos Inmunológicos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Transformación Celular Neoplásica / Linfoma Folicular / Rituximab / Antineoplásicos Inmunológicos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2018 Tipo del documento: Article